WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$34.71
+0.58% today
Updated 2026-05-06
Market cap
$1.91B
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$55 – $171
Volume
1.0M
GeneDx Holdings Corp. (WGS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.92%
Operating margin
-10.60%
ROE
-7.60%
ROA
-1.55%
Debt/equity
0.39x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $196.17M | $-29.70M | 42.20% | -15.50% | -15.14% |
| 2020 | $179.32M | $-241.34M | 2.25% | -134.95% | -134.58% |
| 2021 | $212.19M | $-245.39M | -7.82% | -210.25% | -115.64% |
| 2022 | $234.69M | $-548.98M | -11.40% | -284.48% | -233.91% |
| 2023 | $202.57M | $-175.77M | 44.43% | -89.15% | -86.77% |
| 2024 | $305.45M | $-52.29M | 63.64% | -7.60% | -17.12% |
| 2025 | $427.54M | $-21.02M | 69.74% | -2.76% | -4.92% |